Nuns should take contraceptive pill to cut cancer risk

By Admin
While writing in the Lancet medical journal two health experts have claimed nuns should take the contraceptive pill to reduce their risk of developing...

While writing in the Lancet medical journal two health experts have claimed nuns should take the contraceptive pill to reduce their risk of developing cancer.

It is commonly believed that women who do not go through pregnancy or breastfeed children are more at risk of developing breast, womb and ovarian cancer as they have more periods in their lifetime.

Studies of nuns have also found that cancer-related mortality rates are higher among nuns than other women.  

To read the latest edition of Healthcare Global, click here

According to the two Australian researchers, overall mortality rates are 12 percent lower in pill-takers and the risk of breast, ovarian and womb cancer is cut by approximately 50-60 percent if women take the pill.

However, nuns have been banned from taking any kind of contraception apart from abstinence.

Professor Roger Short, from the University of Melbourne, and Dr Kara Britt, from Melbourne’s Monash University, said in their Lancet opinion article that nuns “pay a terrible price for their chastity because they have a greatly increased risk of breast, ovarian, and uterine cancers.

They also said: “The Catholic church condemns all forms of contraception except abstinence, as outlined by Pope Paul VI in Humanae Vitae in 1968.

“If the Catholic Church could make the contraceptive pill freely available to all its nuns, it would reduce the risk of those accursed pests, cancer of the ovary and uterus, and give nuns’ plight the recognition it deserves.”

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare